Global Autoimmunity Reagents Industry Growth and Trends Forecast to 2031

Summary

Autoimmune diseases refer to diseases caused by the body's immune response to self-antigens, resulting in damage to its own tissues. Common autoimmune diseases include rheumatoid arthritis, systemic lupus erythematosus and vasculitis.

According to APO Research, The global Autoimmunity Reagents market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Autoimmunity Reagents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Autoimmunity Reagents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Autoimmunity Reagents is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Autoimmunity Reagents include EUROIMMUN, HUMAN, Bio-Rad Laboratories, AESKU, Inova, MBL, Orgentec, Trinity and Phadia, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Autoimmunity Reagents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmunity Reagents.

The Autoimmunity Reagents market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmunity Reagents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Autoimmunity Reagents Segment by Company

EUROIMMUN
HUMAN
Bio-Rad Laboratories
AESKU
Inova
MBL
Orgentec
Trinity
Phadia
HOB Biotech
Shenzhen YHLO Biotech
Kangrun Biotech
Immuno-Biological Laboratories
Biomedical diagnostics
Shanghai Kexin

Autoimmunity Reagents Segment by Type

BLOT
ELISA
IFA
CLIA

Autoimmunity Reagents Segment by Application

Hospital
Third-Party Testing Agency

Autoimmunity Reagents Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Autoimmunity Reagents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Autoimmunity Reagents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Autoimmunity Reagents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmunity Reagents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Autoimmunity Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Autoimmunity Reagents Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Autoimmunity Reagents Sales Estimates and Forecasts (2020-2031)
1.3 Autoimmunity Reagents Market by Type
1.3.1 BLOT
1.3.2 ELISA
1.3.3 IFA
1.3.4 CLIA
1.4 Global Autoimmunity Reagents Market Size by Type
1.4.1 Global Autoimmunity Reagents Market Size Overview by Type (2020-2031)
1.4.2 Global Autoimmunity Reagents Historic Market Size Review by Type (2020-2025)
1.4.3 Global Autoimmunity Reagents Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Autoimmunity Reagents Sales Breakdown by Type (2020-2025)
1.5.2 Europe Autoimmunity Reagents Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Autoimmunity Reagents Sales Breakdown by Type (2020-2025)
1.5.4 South America Autoimmunity Reagents Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Autoimmunity Reagents Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Autoimmunity Reagents Industry Trends
2.2 Autoimmunity Reagents Industry Drivers
2.3 Autoimmunity Reagents Industry Opportunities and Challenges
2.4 Autoimmunity Reagents Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Autoimmunity Reagents Revenue (2020-2025)
3.2 Global Top Players by Autoimmunity Reagents Sales (2020-2025)
3.3 Global Top Players by Autoimmunity Reagents Price (2020-2025)
3.4 Global Autoimmunity Reagents Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Autoimmunity Reagents Major Company Production Sites & Headquarters
3.6 Global Autoimmunity Reagents Company, Product Type & Application
3.7 Global Autoimmunity Reagents Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Autoimmunity Reagents Market CR5 and HHI
3.8.2 Global Top 5 and 10 Autoimmunity Reagents Players Market Share by Revenue in 2024
3.8.3 2023 Autoimmunity Reagents Tier 1, Tier 2, and Tier 3
4 Autoimmunity Reagents Regional Status and Outlook

4.1 Global Autoimmunity Reagents Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Autoimmunity Reagents Historic Market Size by Region
4.2.1 Global Autoimmunity Reagents Sales in Volume by Region (2020-2025)
4.2.2 Global Autoimmunity Reagents Sales in Value by Region (2020-2025)
4.2.3 Global Autoimmunity Reagents Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Autoimmunity Reagents Forecasted Market Size by Region
4.3.1 Global Autoimmunity Reagents Sales in Volume by Region (2026-2031)
4.3.2 Global Autoimmunity Reagents Sales in Value by Region (2026-2031)
4.3.3 Global Autoimmunity Reagents Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Autoimmunity Reagents by Application

5.1 Autoimmunity Reagents Market by Application
5.1.1 Hospital
5.1.2 Third-Party Testing Agency
5.2 Global Autoimmunity Reagents Market Size by Application
5.2.1 Global Autoimmunity Reagents Market Size Overview by Application (2020-2031)
5.2.2 Global Autoimmunity Reagents Historic Market Size Review by Application (2020-2025)
5.2.3 Global Autoimmunity Reagents Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Autoimmunity Reagents Sales Breakdown by Application (2020-2025)
5.3.2 Europe Autoimmunity Reagents Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Autoimmunity Reagents Sales Breakdown by Application (2020-2025)
5.3.4 South America Autoimmunity Reagents Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Autoimmunity Reagents Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 EUROIMMUN
6.1.1 EUROIMMUN Comapny Information
6.1.2 EUROIMMUN Business Overview
6.1.3 EUROIMMUN Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 EUROIMMUN Autoimmunity Reagents Product Portfolio
6.1.5 EUROIMMUN Recent Developments
6.2 HUMAN
6.2.1 HUMAN Comapny Information
6.2.2 HUMAN Business Overview
6.2.3 HUMAN Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 HUMAN Autoimmunity Reagents Product Portfolio
6.2.5 HUMAN Recent Developments
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Comapny Information
6.3.2 Bio-Rad Laboratories Business Overview
6.3.3 Bio-Rad Laboratories Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bio-Rad Laboratories Autoimmunity Reagents Product Portfolio
6.3.5 Bio-Rad Laboratories Recent Developments
6.4 AESKU
6.4.1 AESKU Comapny Information
6.4.2 AESKU Business Overview
6.4.3 AESKU Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AESKU Autoimmunity Reagents Product Portfolio
6.4.5 AESKU Recent Developments
6.5 Inova
6.5.1 Inova Comapny Information
6.5.2 Inova Business Overview
6.5.3 Inova Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Inova Autoimmunity Reagents Product Portfolio
6.5.5 Inova Recent Developments
6.6 MBL
6.6.1 MBL Comapny Information
6.6.2 MBL Business Overview
6.6.3 MBL Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MBL Autoimmunity Reagents Product Portfolio
6.6.5 MBL Recent Developments
6.7 Orgentec
6.7.1 Orgentec Comapny Information
6.7.2 Orgentec Business Overview
6.7.3 Orgentec Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Orgentec Autoimmunity Reagents Product Portfolio
6.7.5 Orgentec Recent Developments
6.8 Trinity
6.8.1 Trinity Comapny Information
6.8.2 Trinity Business Overview
6.8.3 Trinity Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Trinity Autoimmunity Reagents Product Portfolio
6.8.5 Trinity Recent Developments
6.9 Phadia
6.9.1 Phadia Comapny Information
6.9.2 Phadia Business Overview
6.9.3 Phadia Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Phadia Autoimmunity Reagents Product Portfolio
6.9.5 Phadia Recent Developments
6.10 HOB Biotech
6.10.1 HOB Biotech Comapny Information
6.10.2 HOB Biotech Business Overview
6.10.3 HOB Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 HOB Biotech Autoimmunity Reagents Product Portfolio
6.10.5 HOB Biotech Recent Developments
6.11 Shenzhen YHLO Biotech
6.11.1 Shenzhen YHLO Biotech Comapny Information
6.11.2 Shenzhen YHLO Biotech Business Overview
6.11.3 Shenzhen YHLO Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shenzhen YHLO Biotech Autoimmunity Reagents Product Portfolio
6.11.5 Shenzhen YHLO Biotech Recent Developments
6.12 Kangrun Biotech
6.12.1 Kangrun Biotech Comapny Information
6.12.2 Kangrun Biotech Business Overview
6.12.3 Kangrun Biotech Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Kangrun Biotech Autoimmunity Reagents Product Portfolio
6.12.5 Kangrun Biotech Recent Developments
6.13 Immuno-Biological Laboratories
6.13.1 Immuno-Biological Laboratories Comapny Information
6.13.2 Immuno-Biological Laboratories Business Overview
6.13.3 Immuno-Biological Laboratories Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Immuno-Biological Laboratories Autoimmunity Reagents Product Portfolio
6.13.5 Immuno-Biological Laboratories Recent Developments
6.14 Biomedical diagnostics
6.14.1 Biomedical diagnostics Comapny Information
6.14.2 Biomedical diagnostics Business Overview
6.14.3 Biomedical diagnostics Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Biomedical diagnostics Autoimmunity Reagents Product Portfolio
6.14.5 Biomedical diagnostics Recent Developments
6.15 Shanghai Kexin
6.15.1 Shanghai Kexin Comapny Information
6.15.2 Shanghai Kexin Business Overview
6.15.3 Shanghai Kexin Autoimmunity Reagents Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shanghai Kexin Autoimmunity Reagents Product Portfolio
6.15.5 Shanghai Kexin Recent Developments
7 North America by Country

7.1 North America Autoimmunity Reagents Sales by Country
7.1.1 North America Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Autoimmunity Reagents Sales by Country (2020-2025)
7.1.3 North America Autoimmunity Reagents Sales Forecast by Country (2026-2031)
7.2 North America Autoimmunity Reagents Market Size by Country
7.2.1 North America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Autoimmunity Reagents Market Size by Country (2020-2025)
7.2.3 North America Autoimmunity Reagents Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Autoimmunity Reagents Sales by Country
8.1.1 Europe Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Autoimmunity Reagents Sales by Country (2020-2025)
8.1.3 Europe Autoimmunity Reagents Sales Forecast by Country (2026-2031)
8.2 Europe Autoimmunity Reagents Market Size by Country
8.2.1 Europe Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Autoimmunity Reagents Market Size by Country (2020-2025)
8.2.3 Europe Autoimmunity Reagents Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Autoimmunity Reagents Sales by Country
9.1.1 Asia-Pacific Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Autoimmunity Reagents Sales by Country (2020-2025)
9.1.3 Asia-Pacific Autoimmunity Reagents Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Autoimmunity Reagents Market Size by Country
9.2.1 Asia-Pacific Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Autoimmunity Reagents Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Autoimmunity Reagents Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Autoimmunity Reagents Sales by Country
10.1.1 South America Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Autoimmunity Reagents Sales by Country (2020-2025)
10.1.3 South America Autoimmunity Reagents Sales Forecast by Country (2026-2031)
10.2 South America Autoimmunity Reagents Market Size by Country
10.2.1 South America Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Autoimmunity Reagents Market Size by Country (2020-2025)
10.2.3 South America Autoimmunity Reagents Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Autoimmunity Reagents Sales by Country
11.1.1 Middle East and Africa Autoimmunity Reagents Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Autoimmunity Reagents Sales by Country (2020-2025)
11.1.3 Middle East and Africa Autoimmunity Reagents Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Autoimmunity Reagents Market Size by Country
11.2.1 Middle East and Africa Autoimmunity Reagents Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Autoimmunity Reagents Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Autoimmunity Reagents Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Autoimmunity Reagents Value Chain Analysis
12.1.1 Autoimmunity Reagents Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Autoimmunity Reagents Production Mode & Process
12.2 Autoimmunity Reagents Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Autoimmunity Reagents Distributors
12.2.3 Autoimmunity Reagents Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings